PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis

Lignende værker

• PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
  af: Remy Piccolo, V, et al.
  Udgivet: (2013)
• Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
  af: Woerner, A, et al.
  Udgivet: (2015)
• PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
  af: Rossetto, E, et al.
  Udgivet: (2013)
• PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
  af: Reinards, TH, et al.
  Udgivet: (2013)
• PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
  af: Swart, JF, et al.
  Udgivet: (2013)